Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2019
The 9th European Lung Cancer Conference
Geneva, Switzerland - 10 Apr - 13 Apr 2019
Presentation Date(s):- 10 Apr - 13 Apr 2019
- Total Presentations: 489
-
+
Proffered Paper session I
- Type: Proffered Paper session
- Presentations: 8
- Coordinates: 4/10/2019, 16:30 - 18:15, Room C
-
+
LBA2 - Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC)
17:30 - 17:45 | Presenter: Marina Chiara Garassino
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Mini Oral session I
- Type: Mini Oral session
- Presentations: 8
- Coordinates: 4/11/2019, 08:00 - 08:50, Room A
-
+
113O - Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001
08:10 - 08:15 | Presenter: Luis Paz-Ares
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Immunotherapy in stage IV
- Type: Educational session
- Presentations: 6
- Coordinates: 4/11/2019, 09:00 - 10:30, Room B
-
+
Combo I-O/Chemo
09:20 - 09:40 | Presenter: Luis Paz-Ares
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Lunch & Poster Display session
- Type: Poster Display session
- Presentations: 170
- Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
-
+
180TiP - An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
12:30 - 12:30 | Presenter: James Spicer
- Abstract
Loading... -
+
185TiP - RATIONALE 001: Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)
12:30 - 12:30 | Presenter: Luis Paz-Ares
- Abstract
Loading...
-
+
ESMO-IASLC Best Abstracts
- Type: Proffered Paper session
- Presentations: 7
- Coordinates: 4/11/2019, 14:45 - 16:15, Room B
-
+
Invited Discussant LBA1_PR and LBA3
15:15 - 15:30 | Presenter: Luis Paz-Ares
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Mini Oral session II
- Type: Mini Oral session
- Presentations: 9
- Coordinates: 4/11/2019, 16:40 - 17:40, Room C
-
+
85O - Prevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC)
16:45 - 16:50 | Presenter: David Planchard
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Medscape Oncology - Industry Satellite Symposium
- Type: Industry Satellite symposium
- Presentations: 5
- Coordinates: 4/12/2019, 13:00 - 14:00, Room A
-
+
Welcome and introduction: Recent practice changing data – What do they mean in the real world?
13:00 - 13:10 | Presenter: Luis Paz-Ares
- Abstract
No abstract available for this presentation
